Drug Profile
Avasimibe
Alternative Names: CI 1011Latest Information Update: 28 Oct 2003
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atherosclerosis; Hyperlipidaemia